- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01309906
Evaluation of the Feasibility a New Silicone Hydrogel Contact Lens
September 29, 2020 updated by: Bausch & Lomb Incorporated
A Study to Evaluate the Product Feasibility of a New Silicone Hydrogel Contact Lens
The objective of this study is to determine the clinical feasibility and to evaluate the product performance of an investigational contact lens.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
66
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
Rochester, New York, United States, 14609
- Bausch & Lomb Incorporated
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Have physiologically normal anterior segments not exhibiting clinically significant biomicroscopy findings.
- Be myopic and require lens correction in each eye.
- Be adapted wearers of soft contact lenses, wear a lens in each eye, and each lens must be of the same manufacture and brand.
Exclusion Criteria:
- Any systemic disease affecting ocular health.
- Using any systemic or topical medications that will affect ocular physiology or lens performance.
- An active ocular disease, any corneal infiltrative response or are using any ocular medications.
- Any "Present" finding during the slit lamp examination that, in the Investigator's judgment, interferes with contact lens wear.
- Allergic to any component in the study care products.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Investigational lens
Bausch & Lomb investigational silicone hydrogel lens
|
Bausch & Lomb investigational silicone hydrogel contact lens worn on a daily wear basis for 1 week.
|
Active Comparator: Air Optix Aqua lens
Ciba Vision Air Optix Aqua contact lens
|
Ciba Visions Air Optix Aqua contact lens, worn on a daily wear basis for 1 week.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Visual Acuity
Time Frame: At 1 week follow up
|
Visual acuity was assessed by distance high contrast logarithm of the minimum angle of resolution (logMAR).
|
At 1 week follow up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Percentage of Eyes With > Grade 2 Slit Lamp Findings
Time Frame: At 1 week follow up
|
Graded slit lamp findings for each eye, including epithelial edema, epithelial microcysts, corneal staining, limbal and bulbar injections, upper lid tarsal conjunctival abnormalities, corneal neovascularization, and corneal infiltrates were graded for severity on a scale from 0 (No Finding) to 4 (Severe Finding).
The outcome measure is any finding > grade 2, across abnormalities.
|
At 1 week follow up
|
Symptoms and Complaints
Time Frame: At 1 week follow up
|
At 1-Week Follow-up, subjects were asked to rate 16 common symptoms/complaints on a scale of 0 to 100, with 100 being the most favorable score.
|
At 1 week follow up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Tara Vaz, OD, Bausch & Lomb Incorporated
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2010
Primary Completion (Actual)
January 1, 2011
Study Completion (Actual)
February 1, 2011
Study Registration Dates
First Submitted
March 4, 2011
First Submitted That Met QC Criteria
March 4, 2011
First Posted (Estimate)
March 7, 2011
Study Record Updates
Last Update Posted (Actual)
October 22, 2020
Last Update Submitted That Met QC Criteria
September 29, 2020
Last Verified
September 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 688E
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myopia
-
He Eye HospitalNot yet recruiting
-
University of BradfordCoopervision, Inc.; University of HuddersfieldNot yet recruiting
-
Visioneering Technologies, IncRecruitingMyopiaUnited States, Canada, Hong Kong, Singapore
-
University Eye Hospital, FreiburgRecruiting
-
Shanghai 10th People's HospitalCompletedMyopia | Myopia, ProgressiveChina
-
Tianjin Eye HospitalActive, not recruiting
-
Tianjin Eye HospitalCompleted
-
Sultan Qaboos UniversityChristian Medical College, Vellore, IndiaUnknown
-
Peking University People's HospitalUnknownProgressive MyopiaChina
-
Shanghai Eye Disease Prevention and Treatment CenterNot yet recruiting
Clinical Trials on Investigational lens
-
Johnson & Johnson Vision Care, Inc.Completed
-
Bausch & Lomb IncorporatedCompleted
-
Bausch & Lomb IncorporatedCompleted
-
Johnson & Johnson Vision Care, Inc.CompletedVisual AcuityUnited States, Hong Kong
-
Bausch & Lomb IncorporatedCompleted
-
Johnson & Johnson Vision Care, Inc.Completed
-
Ohio State UniversityMyoptechsCompleted
-
Bausch & Lomb IncorporatedCompleted
-
Abbott Medical OpticsCompleted
-
Bausch & Lomb IncorporatedCompletedCorneal DeformityUnited States